[go: up one dir, main page]

UA73804C2 - Anticholinergic agents being used as medicaments, a method for the preparation thereof and a pharmaceutical composition - Google Patents

Anticholinergic agents being used as medicaments, a method for the preparation thereof and a pharmaceutical composition Download PDF

Info

Publication number
UA73804C2
UA73804C2 UA2003054186A UA2003054186A UA73804C2 UA 73804 C2 UA73804 C2 UA 73804C2 UA 2003054186 A UA2003054186 A UA 2003054186A UA 2003054186 A UA2003054186 A UA 2003054186A UA 73804 C2 UA73804 C2 UA 73804C2
Authority
UA
Ukraine
Prior art keywords
group
methyl
compounds
general formula
residue
Prior art date
Application number
UA2003054186A
Other languages
English (en)
Ukrainian (uk)
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of UA73804C2 publication Critical patent/UA73804C2/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
UA2003054186A 2000-10-14 2001-09-28 Anticholinergic agents being used as medicaments, a method for the preparation thereof and a pharmaceutical composition UA73804C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10050994A DE10050994A1 (de) 2000-10-14 2000-10-14 Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
PCT/EP2001/011226 WO2002032899A1 (fr) 2000-10-14 2001-09-28 Agents anticholinergiques pouvant etre employes en tant que medicaments, et procedes de fabrication

Publications (1)

Publication Number Publication Date
UA73804C2 true UA73804C2 (en) 2005-09-15

Family

ID=7659808

Family Applications (1)

Application Number Title Priority Date Filing Date
UA2003054186A UA73804C2 (en) 2000-10-14 2001-09-28 Anticholinergic agents being used as medicaments, a method for the preparation thereof and a pharmaceutical composition

Country Status (37)

Country Link
EP (2) EP1382606A3 (fr)
JP (2) JP4109106B2 (fr)
KR (1) KR100830359B1 (fr)
CN (1) CN1275962C (fr)
AR (1) AR035589A1 (fr)
AT (1) ATE259805T1 (fr)
AU (2) AU2002213975B2 (fr)
BG (1) BG66225B1 (fr)
BR (1) BR0114635A (fr)
CA (1) CA2425557C (fr)
DE (2) DE10050994A1 (fr)
DK (1) DK1325001T3 (fr)
EA (1) EA005816B1 (fr)
EC (1) ECSP034542A (fr)
EE (1) EE05179B1 (fr)
ES (1) ES2215147T3 (fr)
HR (1) HRP20030278B1 (fr)
HU (1) HUP0301203A3 (fr)
IL (2) IL155334A0 (fr)
ME (1) MEP39908A (fr)
MX (1) MXPA03003160A (fr)
MY (1) MY127144A (fr)
NO (1) NO328207B1 (fr)
NZ (1) NZ525836A (fr)
PE (1) PE20020433A1 (fr)
PL (1) PL207311B1 (fr)
PT (1) PT1325001E (fr)
RS (1) RS50464B (fr)
SA (1) SA01220414B1 (fr)
SI (1) SI1325001T1 (fr)
SK (1) SK287138B6 (fr)
TR (1) TR200400376T4 (fr)
TW (1) TWI306098B (fr)
UA (1) UA73804C2 (fr)
UY (1) UY26958A1 (fr)
WO (1) WO2002032899A1 (fr)
ZA (1) ZA200302914B (fr)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10200943A1 (de) * 2002-01-12 2003-07-24 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Scopinestern
DE10203753A1 (de) * 2002-01-31 2003-08-14 Boehringer Ingelheim Pharma Neue Xanthencarbonsäureester, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
US7405224B2 (en) 2002-01-31 2008-07-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Xanthenecarboxylates, processes for preparing them, and their use as pharmaceutical compositions
CN1646527A (zh) * 2002-04-12 2005-07-27 贝林格尔英格海姆法玛两合公司 包含β模拟剂(BETAMIMETICS)及新颖抗胆碱酯酶的药物
DE10216429A1 (de) * 2002-04-12 2003-10-23 Boehringer Ingelheim Pharma Arzneimittel enthaltend Steroide und ein neues Anticholinergikum
US7084153B2 (en) 2002-04-12 2006-08-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments comprising steroids and a novel anticholinergic
DE10256317A1 (de) * 2002-04-12 2003-10-23 Boehringer Ingelheim Pharma Arzneimittel enthaltend Betamimetika und ein neues Anticholinergikum
US7417051B2 (en) 2002-04-12 2008-08-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments comprising betamimetics and a novel anticholinergic
DE10224091A1 (de) * 2002-05-31 2003-12-11 Boehringer Ingelheim Pharma Technisches Verfahren zur Herstellung von Tropenol
DE10230750A1 (de) * 2002-07-09 2004-01-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkompositionen auf der Basis neuer Anticholonergika und NK1-Rezeptor-Antagonisten
DE10230751A1 (de) * 2002-07-09 2004-01-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkompositionen auf der Basis neuer Anticholinergika und EGFR-Kinase-Hemmern
DE10230769A1 (de) * 2002-07-09 2004-01-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkompositionen auf der Basis neuer Anticholinergika und PDE-IV-Inhibitoren
ES2278170T3 (es) * 2002-07-09 2007-08-01 BOEHRINGER INGELHEIM PHARMA GMBH &amp; CO.KG Composiciones farmaceuticas de anticolinergicos e inhibidores de la quinasa p38 en el tratamiento de enfermedades respiratorias.
AU2003298473B9 (en) * 2002-08-14 2011-06-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosol formulation for inhalation containing an anticholinergic agent
US7244742B2 (en) 2002-08-17 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co Kg Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic
DE10237739A1 (de) * 2002-08-17 2004-02-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalative Arzneimittel enthaltend ein neues Anticholinergikum in Kombination mit Corticosteroiden und Betamimetika
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
DE10317461A1 (de) 2003-04-16 2004-10-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Radioaktiv markierte Mikropartikel, Verfahren zu deren Herstellung und deren Verwendung
DE10323966A1 (de) * 2003-05-27 2004-12-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue langwirksame Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen
US7332175B2 (en) 2003-05-27 2008-02-19 Boehringer Ingelheim International Gmbh Long-acting drug combinations for the treatment of respiratory complaints
DE10331350A1 (de) * 2003-07-11 2005-01-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulverformulierungen für die Inhalation enthaltend ein neues Anticholinergikum
US7273603B2 (en) 2003-07-11 2007-09-25 Boehringer Ingelheim International Gmbh HFC solution formulations containing an anticholinergic
US7462367B2 (en) 2003-07-11 2008-12-09 Boehringer Ingelheim International Gmbh Anticholinergic powder formulations for inhalation
EP1651208A1 (fr) * 2003-07-28 2006-05-03 Boehringer Ingelheim International GmbH Medicaments comprenant des inhibiteurs de pde iv et un nouvel anticholinergique, et leur utilisation pour le traitement de troubles respiratoires
ES2326320T3 (es) * 2003-07-28 2009-10-07 Boehringer Ingelheim International Gmbh Medicamentos para inhalacion que comprenden esteroides y nuevo ester del acido fluorencarboxilico.
EP1651221B1 (fr) * 2003-07-28 2009-01-14 Boehringer Ingelheim International Gmbh Medicaments pour inhalation comportant des agents a activite betamimetique et anticholinergique
KR20060052911A (ko) * 2003-07-29 2006-05-19 베링거 인겔하임 인터내셔날 게엠베하 베타흥분제와 항콜린제를 포함하는 흡입용 의약품
EP1651224B1 (fr) * 2003-07-31 2011-10-05 Boehringer Ingelheim International GmbH Medicaments pour inhalation comportant un agent a activite anticholinergique et un betamimetique
EP1504756A1 (fr) * 2003-08-06 2005-02-09 Kyowa Hakko Kogyo Co., Ltd Compositions de médicaments contenant un composé hétérocyclique et un anticholinergique
DE10345065A1 (de) * 2003-09-26 2005-04-14 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
CA2547394A1 (fr) * 2004-01-09 2005-07-28 Boehringer Ingelheim International Gmbh Nouvelles compositions pharmaceutiques a base de derives de scopineester et de nicotinamide
US20050186175A1 (en) * 2004-02-20 2005-08-25 Boehringer Ingelheim International Gmbh Pharmaceutical compositions based on benzilic acid esters and soluble TNF receptor fusion proteins
EP1718301A1 (fr) * 2004-02-20 2006-11-08 Boehringer Ingelheim International GmbH Compositions pharmaceutiques a base d'anticholinergiques et de pegsunercept
US7507745B2 (en) 2004-02-20 2009-03-24 Boehringer Ingelheim International Gmbh Pharmaceutical compositions based on fluorenecarboxylic acid esters and soluble TNF receptor fusion proteins
DE102004016179A1 (de) * 2004-03-30 2005-10-20 Boehringer Ingelheim Pharma Verbindungen zur Behandlung von proliferativen Prozessen
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
ES2322148T3 (es) * 2004-08-11 2009-06-17 BOEHRINGER INGELHEIM PHARMA GMBH &amp; CO. KG Medicamentos que contienen anticolinergicos para el tratamiento en las vias urinarias.
DE102004056578A1 (de) * 2004-11-23 2006-05-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalative Arzneimittel enthaltend ein neues Anticholinergikum, Formoterol und ein Steroid
WO2006087316A1 (fr) * 2005-02-16 2006-08-24 Boehringer Ingelheim International Gmbh Compositions pharmaceutiques comprenant des anticholinergiques et de l’etiprednol
WO2006094924A2 (fr) * 2005-03-09 2006-09-14 Boehringer Ingelheim International Gmbh Nouvelles compositions pharmaceutiques a base d'anticholinergiques et d'inhibiteurs de pde 5
WO2006128847A2 (fr) * 2005-05-31 2006-12-07 Boehringer Ingelheim International Gmbh Nouvelles combinaisons medicamenteuses pour le traitement de maladies respiratoires
EP1898894A1 (fr) * 2005-06-17 2008-03-19 Boehringer Ingelheim International GmbH Inhibiteurs mrp iv pour le traitement de maladies respiratoires
DE102005030733A1 (de) 2005-07-01 2007-01-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen enthaltend langwirksame Beta-2-Agonisten und wenigstens einen weiteren Wirkstoff
DK1917253T3 (da) 2005-08-15 2015-03-30 Boehringer Ingelheim Int Fremgangsmåde til fremstilling af betamimetika
WO2007045979A1 (fr) 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Compositions pharmaceutiques d'antagonistes du recepteur muscarinique
DE102005055963A1 (de) * 2005-11-24 2007-07-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
DE102005055957A1 (de) * 2005-11-24 2007-07-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
DE102005055961A1 (de) * 2005-11-24 2007-05-31 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
EP2051714B1 (fr) 2006-08-07 2011-04-13 Boehringer Ingelheim International GmbH Combinaisons de médicaments pour le traitement des infections des voies respiratoires
EP1958947A1 (fr) 2007-02-15 2008-08-20 Ranbaxy Laboratories Limited Inhibiteurs de la phosphodiestérase de type 4
DK2124944T3 (da) 2007-03-14 2012-04-23 Ranbaxy Lab Ltd Pyrazolo[3,4-b]pyridinderivater som phosphodiesteraseinhibitorer
ES2569359T3 (es) 2007-07-06 2016-05-10 Vectura Delivery Devices Limited Inhalador
EP2180892A2 (fr) * 2007-07-18 2010-05-05 Boehringer Ingelheim International GmbH Combinaisons contenant telmisartan et un agent anticholinergique comme le tiotropium ou un sel de glycopyrrionium pour le traitement de maladies respiratoires comme le bpco ou l'asthma
EP2077132A1 (fr) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispositif distributeur, dispositif de stockage et procédé pour la distribution d'une formulation
EP2082771A1 (fr) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Inhalateur
EP2082768A1 (fr) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Inhalateur
EP2082772A1 (fr) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Inhalateur
EP2082767A1 (fr) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Inhalateur
EP2082766A1 (fr) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Formation d'une spirale de bande alvéolée
EP2111861A1 (fr) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions d'inhibiteurs de type IV de la phosphodiestérase
JP5670421B2 (ja) 2009-03-31 2015-02-18 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング コンポーネント表面のコーティング方法
EP2432531B1 (fr) 2009-05-18 2019-03-06 Boehringer Ingelheim International GmbH Adaptateur, dispositif d'inhalation et pulvérisateur
GB0918450D0 (en) 2009-10-21 2009-12-09 Innovata Ltd Composition
WO2011064164A1 (fr) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nébuliseur
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
JP5658268B2 (ja) 2009-11-25 2015-01-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
WO2011160932A1 (fr) 2010-06-24 2011-12-29 Boehringer Ingelheim International Gmbh Nébuliseur
EP2694220B1 (fr) 2011-04-01 2020-05-06 Boehringer Ingelheim International GmbH Appareil médical pourvu d'un récipient
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (fr) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Pulvérisateur comprenant des moyens de détrompage
BR112015010842B1 (pt) 2012-12-21 2021-03-30 Boehringer Ingelheim Vetmedica Gmbh Uso da ciclesonida para o tratamento de doença das vias respiratórias em cavalos
WO2014096116A1 (fr) 2012-12-21 2014-06-26 Boehringer Ingelheim Vetmedica Gmbh Formulation pharmaceutique comprenant du ciclésonide
EP3030298B1 (fr) 2013-08-09 2017-10-11 Boehringer Ingelheim International GmbH Nébuliseur
PL2835146T3 (pl) 2013-08-09 2021-04-06 Boehringer Ingelheim International Gmbh Nebulizator
EA032850B1 (ru) 2014-05-07 2019-07-31 Бёрингер Ингельхайм Интернациональ Гмбх Контейнер, небулайзер и способ изготовления контейнера
LT4242916T (lt) 2014-05-07 2025-12-29 Boehringer Ingelheim International Gmbh Purkštuvas
ES2874029T3 (es) 2014-05-07 2021-11-04 Boehringer Ingelheim Int Nebulizador
RS59613B1 (sr) * 2014-06-18 2020-01-31 Boehringer Ingelheim Vetmedica Gmbh Muskarinski antagonisti i njihove kombinacije za lečenje bolesti disajnih puteva kod konja
DK3344627T5 (da) * 2015-09-04 2021-08-30 Janssen Pharmaceutica Nv Terapeutiske forbindelser til smerte og syntese deraf
CN113292574B (zh) * 2020-02-21 2022-05-03 四川大学 一类手性多环的托品烷化合物及其制备方法和用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4003270A1 (de) * 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgase und ihre verwendung in arzneimittelzubereitungen
DE4108393A1 (de) * 1991-03-15 1992-09-17 Boehringer Ingelheim Kg Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln

Also Published As

Publication number Publication date
BR0114635A (pt) 2004-02-10
TWI306098B (en) 2009-02-11
BG66225B1 (bg) 2012-06-29
KR100830359B1 (ko) 2008-05-20
CA2425557C (fr) 2007-11-13
JP4109106B2 (ja) 2008-07-02
RS50464B (sr) 2010-03-02
HK1060566A1 (en) 2004-08-13
CN1468236A (zh) 2004-01-14
SA01220414B1 (ar) 2007-01-20
IL155334A0 (en) 2003-11-23
SK287138B6 (sk) 2010-01-07
PT1325001E (pt) 2004-07-30
MEP39908A (en) 2011-02-10
SK4352003A3 (en) 2003-08-05
YU29503A (sh) 2006-03-03
EP1325001B1 (fr) 2004-02-18
SI1325001T1 (sl) 2004-08-31
EP1382606A3 (fr) 2004-10-13
HRP20030278B1 (en) 2006-02-28
EP1382606A2 (fr) 2004-01-21
BG107688A (bg) 2003-09-30
HRP20030278A2 (en) 2005-02-28
UY26958A1 (es) 2002-06-20
AU1397502A (en) 2002-04-29
HUP0301203A2 (hu) 2003-10-28
AR035589A1 (es) 2004-06-16
NZ525836A (en) 2004-09-24
PL207311B1 (pl) 2010-11-30
PL360673A1 (en) 2004-09-20
ECSP034542A (es) 2003-06-25
EE200300151A (et) 2003-06-16
CA2425557A1 (fr) 2003-04-11
PE20020433A1 (es) 2002-06-28
EP1325001A1 (fr) 2003-07-09
NO328207B1 (no) 2010-01-11
AU2002213975B2 (en) 2006-11-09
ES2215147T3 (es) 2004-10-01
IL155334A (en) 2009-02-11
DE50101524D1 (de) 2004-03-25
NO20031693D0 (no) 2003-04-11
NO20031693L (no) 2003-05-28
EA200300459A1 (ru) 2003-10-30
MXPA03003160A (es) 2005-09-09
CN1275962C (zh) 2006-09-20
TR200400376T4 (tr) 2004-03-22
WO2002032899A1 (fr) 2002-04-25
DK1325001T3 (da) 2004-06-21
HUP0301203A3 (en) 2006-05-29
ATE259805T1 (de) 2004-03-15
EE05179B1 (et) 2009-06-15
JP2008120834A (ja) 2008-05-29
MY127144A (en) 2006-11-30
JP2004511557A (ja) 2004-04-15
KR20030041165A (ko) 2003-05-23
DE10050994A1 (de) 2002-04-18
ZA200302914B (en) 2003-11-14
EA005816B1 (ru) 2005-06-30

Similar Documents

Publication Publication Date Title
UA73804C2 (en) Anticholinergic agents being used as medicaments, a method for the preparation thereof and a pharmaceutical composition
US7569581B2 (en) Anticholinergics which may be used as medicaments as well as processes for preparing them
JP4484522B2 (ja) 新規フルオレンカルボン酸エステル、その製造方法及び薬物としてのその使用
JP5629420B2 (ja) 新規な抗コリン作用薬、それらの調製方法及び医薬組成物としてのそれらの使用
JP4484521B2 (ja) 抗コリン作用薬、その製造方法及び薬物としてのその使用
JP4554936B2 (ja) Ｍ３アンタゴニストとしてのトロペノール及びスコピンのキサンテンカルボン酸エステル、その製造方法及び薬物としてのその使用
JP2005516067A6 (ja) 新規フルオレンカルボン酸エステル、その製造方法及び薬物としてのその使用
EP1957451B1 (fr) Zwitterions anticholinergiques moderes
GB2208862A (en) Esters and amides of cyclic carboxylic acids and cyclic alcohols and amines
CN111620815B (zh) 手性氯喹、羟氯喹和其衍生物及其制备方法与用途
JP2006514010A (ja) 抗コリン作用を有するカルバミン酸エステル
JP4589006B2 (ja) ムスカリン様ｍ３受容体の拮抗薬としてのヒドロキシ置換窒素複素環の新規エステル、その調製法並びに製薬組成物としてのその使用
HK1082376B (en) Fluorene carboxylic acid esters, methods for the production thereof, and use of the same for preparing pharmaceuticals
DE102005035575A1 (de) Neue Verbindungen zur Behandlung von entzündlichen Erkrankungen